(CRGY) Crescent Energy - Overview
Sector: EnergyIndustry: Oil & Gas E&P | Exchange NYSE (USA) | Currency USD | Market Cap: 4.289m | Total Return 27.7% in 12m
Stock: Oil, Gas, Liquids
Total Rating 40
Risk 61
Buy Signal 0.33
| Risk 5d forecast | |
|---|---|
| Volatility | 44.6% |
| Relative Tail Risk | -0.27% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.64 |
| Alpha | 7.72 |
| Character TTM | |
|---|---|
| Beta | 1.579 |
| Beta Downside | 2.572 |
| Drawdowns 3y | |
|---|---|
| Max DD | 55.95% |
| CAGR/Max DD | 0.21 |
EPS (Earnings per Share)
Revenue
Description: CRGY Crescent Energy March 05, 2026
Crescent Energy Co. (CRGY) is a U.S.-based energy company focused on the exploration and production of crude oil, natural gas, and natural gas liquids. This business model involves extracting hydrocarbons from underground reservoirs.
The companys operations are concentrated in Texas and the Rocky Mountain region, key areas for oil and gas development within the United States.
Founded in 2011 and headquartered in Houston, Texas, CRGY operates within the Oil & Gas Exploration & Production GICS sub-industry. Further research on platforms like ValueRay can provide deeper insights into CRGYs performance and market position.
Headlines to watch out for
- Crude oil price fluctuations impact exploration and production revenue
- Natural gas price volatility affects profitability
- Regulatory changes in environmental policy increase operating costs
- Acquisition strategy drives reserve growth and production expansion
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 132.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA -1.02 > 1.0 |
| NWC/Revenue: 16.81% < 20% (prev -1.34%; Δ 18.15% < -1%) |
| CFO/TA 0.14 > 3% & CFO 1.68b > Net Income 132.9m |
| Net Debt (5.53b) to EBITDA (1.67b): 3.32 < 3 |
| Current Ratio: 1.48 > 1.5 & < 3 |
| Outstanding Shares: last quarter (327.9m) vs 12m ago 39.37% < -2% |
| Gross Margin: 66.72% > 18% (prev 0.82%; Δ 6.59k% > 0.5%) |
| Asset Turnover: 33.14% > 50% (prev 31.99%; Δ 1.15% > 0%) |
| Interest Coverage Ratio: 1.68 > 6 (EBITDA TTM 1.67b / Interest Expense TTM 298.4m) |
Altman Z'' 0.63
| A: 0.05 (Total Current Assets 1.86b - Total Current Liabilities 1.26b) / Total Assets 12.44b |
| B: 0.0 (Retained Earnings 0.0 / Total Assets 12.44b) |
| C: 0.05 (EBIT TTM 500.1m / Avg Total Assets 10.80b) |
| D: 0.00 (Book Value of Equity 33.0k / Total Liabilities 7.28b) |
| Altman-Z'' Score: 0.63 = B |
Beneish M -2.69
| DSRI: 1.12 (Receivables 742.8m/542.3m, Revenue 3.58b/2.93b) |
| GMI: 1.23 (GM 66.72% / 81.96%) |
| AQI: 0.99 (AQ_t 0.02 / AQ_t-1 0.02) |
| SGI: 1.22 (Revenue 3.58b / 2.93b) |
| TATA: -0.12 (NI 132.9m - CFO 1.68b) / TA 12.44b) |
| Beneish M-Score: -2.69 (Cap -4..+1) = A |
What is the price of CRGY shares?
As of March 29, 2026, the stock is trading at USD 13.70 with a total of 6,008,707 shares traded.
Over the past week, the price has changed by +8.13%, over one month by +18.70%, over three months by +65.95% and over the past year by +27.69%.
Over the past week, the price has changed by +8.13%, over one month by +18.70%, over three months by +65.95% and over the past year by +27.69%.
Is CRGY a buy, sell or hold?
Crescent Energy has received a consensus analysts rating of 4.50.
Therefore, it is recommended to buy CRGY.
- StrongBuy: 9
- Buy: 0
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CRGY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 15.2 | 10.9% |
| Analysts Target Price | 15.2 | 10.9% |
CRGY Fundamental Data Overview March 26, 2026
P/E Trailing = 24.2222
P/E Forward = 9.6154
P/S = 1.1981
P/B = 0.8315
Revenue TTM = 3.58b USD
EBIT TTM = 500.1m USD
EBITDA TTM = 1.67b USD
Long Term Debt = 5.52b USD (from longTermDebt, last quarter)
Short Term Debt = 182.2m USD (from shortTermDebt, last quarter)
Debt = 5.53b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.53b USD (from netDebt column, last quarter)
Enterprise Value = 9.82b USD (4.29b + Debt 5.53b - CCE 290k)
Interest Coverage Ratio = 1.68 (Ebit TTM 500.1m / Interest Expense TTM 298.4m)
EV/FCF = -63.26x (Enterprise Value 9.82b / FCF TTM -155.2m)
FCF Yield = -1.58% (FCF TTM -155.2m / Enterprise Value 9.82b)
FCF Margin = -4.34% (FCF TTM -155.2m / Revenue TTM 3.58b)
Net Margin = 3.71% (Net Income TTM 132.9m / Revenue TTM 3.58b)
Gross Margin = 66.72% ((Revenue TTM 3.58b - Cost of Revenue TTM 1.19b) / Revenue TTM)
Gross Margin QoQ = 18.39% (prev 81.11%)
Tobins Q-Ratio = 0.79 (Enterprise Value 9.82b / Total Assets 12.44b)
Interest Expense / Debt = 1.40% (Interest Expense 77.4m / Debt 5.53b)
Taxrate = 17.11% (34.5m / 201.7m)
NOPAT = 414.5m (EBIT 500.1m * (1 - 17.11%))
Current Ratio = 1.48 (Total Current Assets 1.86b / Total Current Liabilities 1.26b)
Debt / Equity = 1.07 (Debt 5.53b / totalStockholderEquity, last quarter 5.17b)
Debt / EBITDA = 3.32 (Net Debt 5.53b / EBITDA 1.67b)
Debt / FCF = -35.63 (negative FCF - burning cash) (Net Debt 5.53b / FCF TTM -155.2m)
Total Stockholder Equity = 4.34b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.23% (Net Income 132.9m / Total Assets 12.44b)
RoE = 3.06% (Net Income TTM 132.9m / Total Stockholder Equity 4.34b)
RoCE = 5.07% (EBIT 500.1m / Capital Employed (Equity 4.34b + L.T.Debt 5.52b))
RoIC = 5.01% (NOPAT 414.5m / Invested Capital 8.27b)
WACC = 5.69% (E(4.29b)/V(9.82b) * Re(11.53%) + D(5.53b)/V(9.82b) * Rd(1.40%) * (1-Tc(0.17)))
Discount Rate = 11.53% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 63.10%
[DCF] Fair Price = unknown (Cash Flow -155.2m)
EPS Correlation: -56.99 | EPS CAGR: -30.43% | SUE: 0.29 | # QB: 0
Revenue Correlation: 46.98 | Revenue CAGR: 10.30% | SUE: -0.73 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.39 | Chg7d=+0.069 | Chg30d=+0.055 | Revisions Net=+0 | Analysts=11
EPS current Year (2026-12-31): EPS=1.50 | Chg7d=+0.179 | Chg30d=+0.218 | Revisions Net=-1 | Growth EPS=-16.8% | Growth Revenue=+24.3%
EPS next Year (2027-12-31): EPS=1.49 | Chg7d=+0.143 | Chg30d=+0.225 | Revisions Net=+1 | Growth EPS=-0.4% | Growth Revenue=+1.2%
[Analyst] Revisions Ratio: +0.00 (3 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.4% (Discount Rate 11.5% - Earnings Yield 4.1%)
[Growth] Growth Spread = +14.3% (Analyst 21.7% - Implied 7.4%)
P/E Forward = 9.6154
P/S = 1.1981
P/B = 0.8315
Revenue TTM = 3.58b USD
EBIT TTM = 500.1m USD
EBITDA TTM = 1.67b USD
Long Term Debt = 5.52b USD (from longTermDebt, last quarter)
Short Term Debt = 182.2m USD (from shortTermDebt, last quarter)
Debt = 5.53b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.53b USD (from netDebt column, last quarter)
Enterprise Value = 9.82b USD (4.29b + Debt 5.53b - CCE 290k)
Interest Coverage Ratio = 1.68 (Ebit TTM 500.1m / Interest Expense TTM 298.4m)
EV/FCF = -63.26x (Enterprise Value 9.82b / FCF TTM -155.2m)
FCF Yield = -1.58% (FCF TTM -155.2m / Enterprise Value 9.82b)
FCF Margin = -4.34% (FCF TTM -155.2m / Revenue TTM 3.58b)
Net Margin = 3.71% (Net Income TTM 132.9m / Revenue TTM 3.58b)
Gross Margin = 66.72% ((Revenue TTM 3.58b - Cost of Revenue TTM 1.19b) / Revenue TTM)
Gross Margin QoQ = 18.39% (prev 81.11%)
Tobins Q-Ratio = 0.79 (Enterprise Value 9.82b / Total Assets 12.44b)
Interest Expense / Debt = 1.40% (Interest Expense 77.4m / Debt 5.53b)
Taxrate = 17.11% (34.5m / 201.7m)
NOPAT = 414.5m (EBIT 500.1m * (1 - 17.11%))
Current Ratio = 1.48 (Total Current Assets 1.86b / Total Current Liabilities 1.26b)
Debt / Equity = 1.07 (Debt 5.53b / totalStockholderEquity, last quarter 5.17b)
Debt / EBITDA = 3.32 (Net Debt 5.53b / EBITDA 1.67b)
Debt / FCF = -35.63 (negative FCF - burning cash) (Net Debt 5.53b / FCF TTM -155.2m)
Total Stockholder Equity = 4.34b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.23% (Net Income 132.9m / Total Assets 12.44b)
RoE = 3.06% (Net Income TTM 132.9m / Total Stockholder Equity 4.34b)
RoCE = 5.07% (EBIT 500.1m / Capital Employed (Equity 4.34b + L.T.Debt 5.52b))
RoIC = 5.01% (NOPAT 414.5m / Invested Capital 8.27b)
WACC = 5.69% (E(4.29b)/V(9.82b) * Re(11.53%) + D(5.53b)/V(9.82b) * Rd(1.40%) * (1-Tc(0.17)))
Discount Rate = 11.53% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 63.10%
[DCF] Fair Price = unknown (Cash Flow -155.2m)
EPS Correlation: -56.99 | EPS CAGR: -30.43% | SUE: 0.29 | # QB: 0
Revenue Correlation: 46.98 | Revenue CAGR: 10.30% | SUE: -0.73 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.39 | Chg7d=+0.069 | Chg30d=+0.055 | Revisions Net=+0 | Analysts=11
EPS current Year (2026-12-31): EPS=1.50 | Chg7d=+0.179 | Chg30d=+0.218 | Revisions Net=-1 | Growth EPS=-16.8% | Growth Revenue=+24.3%
EPS next Year (2027-12-31): EPS=1.49 | Chg7d=+0.143 | Chg30d=+0.225 | Revisions Net=+1 | Growth EPS=-0.4% | Growth Revenue=+1.2%
[Analyst] Revisions Ratio: +0.00 (3 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.4% (Discount Rate 11.5% - Earnings Yield 4.1%)
[Growth] Growth Spread = +14.3% (Analyst 21.7% - Implied 7.4%)